kff employer health benefits survey 2025 glp-1 coverage In 2025: Family Premiums Rise 6 Percent, Large Employers Increase Of GLP-1s For Weight Loss California Health Benefits Survey 2025

Its more than a supplement

Tirzepatide safety data Tirzepatide safety data comes from the SURPASS and SURMOUNT trial programs involving thousands of subjects

Suicidal Ideation and Other Rare Undesirable Effects With the expanding role in diabetes and obesity, as well as potential extending therapeutic uses in the neurological area (e.g., stroke, neurodegenerative disorders, alcohol- and substance-use disorders), rare side effects have recently emerged

For safe disposal of used needles and pens, follow the FDA's guidance on safe sharps disposal

doi: 10.1179/135100009X392539 294 WilliamsB

Hormonal and blood-sugar disruption, including elevated cortisol and prolactin, reduced insulin sensitivity, and hypoglycemia risk tied to IGF-1 receptor activity